• Western blot analysis of extracts of various cell lines, using DEDD2 antibody (STJ110580) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 5s.

Anti-DEDD2 antibody (1-240) (STJ110580)

SKU:
STJ110580

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-DEDD2 (1-240) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: DEDD2
Gene ID: 162989
Uniprot ID: DEDD2_HUMAN
Immunogen Region: 1-240
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-240 of human DEDD2 (NP_579874.1).
Immunogen Sequence: MALSGSTPAPCWEEDECLDY YGMLSLHRMFEVVGGQLTEC ELELLAFLLDEAPGAAGGLA RARSGLELLLELERRGQCDE SNLRLLGQLLRVLARHDLLP HLARKRRRPVSPERYSYGTS SSSKRTEGSCRRRRQSSSSA NSQQGQWETGSPPTKRQRRS RGRPSGGARRRRRGAPAAPQ QQSEPARPSSEGKVTCDIRL RVRAEYCEHGPALEQGVASR RPQALARQLDVFGQATAVL
Tissue Specificity Expressed in most tissues. High levels were found in liver, kidney, heart, ovary, spleen, testes, skeletal muscle and peripheral blood leukocytes. Expression was absent or low in colon and small intestine. Expression is relatively high in the tumor cell lines chronic myologenous leukemia K-562 and the colorectal adenocarcinoma SW480. Expression is moderate in the cervical carcinoma HeLa, the Burkitt's lymphoma Raji, the lung carcinoma A-549, and the melanoma G-361. In contrast, two leukemia cell lines, HL-60 (promyelocytic leukemia) and MOLT-4 (lymphoblastic leukemia), show relatively low levels.
Function May play a critical role in death receptor-induced apoptosis and may target CASP8 and CASP10 to the nucleus. May regulate degradation of intermediate filaments during apoptosis. May play a role in the general transcription machinery in the nucleus and might be an important regulator of the activity of GTF3C3.
Protein Name Dna-Binding Death Effector Domain-Containing Protein 2
Ded-Containing Protein Flame-3
Fadd-Like Anti-Apoptotic Molecule 3
Cellular Localisation Nucleus
Nucleolus
Nuclear
Accumulated In Subnuclear Structures Resembling Nucleoli
Alternative Antibody Names Anti-Dna-Binding Death Effector Domain-Containing Protein 2 antibody
Anti-Ded-Containing Protein Flame-3 antibody
Anti-Fadd-Like Anti-Apoptotic Molecule 3 antibody
Anti-DEDD2 antibody
Anti-FLAME3 antibody
Anti-PSEC0004 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance